• Perrigo Co., of Allegan, Mich., filed an abbreviated new drug application with the FDA for a generic version of Axiron (testosterone) topical solution, originally developed by Acrux Ltd., of Melbourne, Australia, and Eli Lilly and Co., of Indianapolis.